| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.4B | $7.3B | $6.2B | $5.1B | $1.1B | $1.0B | $0.8B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $2.6B | $2.5B | $2.3B | $1.9B | $1.7B | $1.5B | $1.2B | $0.9B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.4B | $0.2B | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Net Income | $0.5B | $1.4B | $-0.4B | $0.0B | $-0.1B | $-0.5B | $-0.4B | $-0.3B |
| EPS (Basic) | $1.98 | $5.28 | $-1.44 | $0.12 | — | — | — | — |
| EPS (Diluted) | $1.95 | $5.21 | $-1.44 | $0.12 | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.0B | $16.5B | $13.5B | $10.5B | $8.7B | $6.8B | $5.5B | $4.9B |
| Current Assets | $10.5B | $9.9B | $8.1B | $5.2B | $4.8B | $3.1B | $2.7B | $4.0B |
| Cash & Equivalents | $1.5B | $2.0B | $1.9B | $1.5B | $1.4B | $0.7B | $0.6B | $1.1B |
| Total Liabilities | $8.9B | $8.4B | $7.9B | $6.0B | $5.4B | $4.3B | $3.6B | $3.4B |
| Current Liabilities | $5.5B | $5.1B | $4.6B | $5.1B | $4.3B | $3.0B | $2.4B | $2.1B |
| Stockholders' Equity | $9.0B | $8.1B | $5.6B | $4.5B | $3.3B | $2.5B | $2.0B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.1B | $1.7B | $1.7B | $1.3B | $0.9B | $0.6B | $0.5B |
| Investing Cash Flow | $-1.8B | $-1.8B | $-2.5B | $-1.6B | $-1.2B | $-0.9B | $-0.8B | $-1.0B |
| Capital Expenditures | $0.3B | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $-0.3B | $1.2B | $0.1B | $0.6B | $0.1B | $-0.3B | $1.1B |